Dopamine D1 Receptor Gene Variation Modulates Opioid Dependence Risk by Affecting Transition to Addiction

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zhu, Feng ^a,b,c   Yan, Chun xia ^a,b,c   Wen, Yi chong ^a,b,c   Wang, Jiayin ^d   Bi, Jinbo ^d,e   Zhao, Ya ling ^a,c   Wei, Lai ^a,b,c   Gao, Cheng ge ^b   Jia, Wei ^f   Li, Sheng bin ^a,b,c  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^f Xi'an Mental Health Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; MORPHINE; OPIATE;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG DEPENDENCE; EUPHORIA; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; SEMI STRUCTURED INTERVIEW; SURVIVAL;

ADULT; AGE OF ONSET; ALLELES; BEHAVIOR, ADDICTIVE; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; OPIOID-RELATED DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RECEPTORS, DOPAMINE D1; RISK; TIME FACTORS;

EID: 84881588009     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070805     Document Type: Article

References (50)

1. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, et al. (1996) Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 67: 473-477.
2. Bierut LJ, (2011) Genetic vulnerability and susceptibility to substance dependence. Neuron 69: 618-627.
3. Gelernter J, Panhuysen C, Wilcox M, Hesselbrock V, Rounsaville B, et al. (2006) Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet 78: 759-769.
4. Chan G, Gelernter J, Oslin D, Farrer L, Kranzler HR, (2011) Empirically derived subtypes of opioid use and related behaviors. Addiction 106: 1146-1154.
5. Sun J, Bi J, Chan G, Oslin D, Farrer L, et al. (2012) Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. Addict Behav 37: 1138-1144.
6. Wagner FA, Anthony JC, (2002) From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26: 479-488.
7. Ridenour TA, Maldonado-Molina M, Compton WM, Spitznagel EL, Cottler LB, (2005) Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. Drug Alcohol Depend 80: 1-14.
8. Deroche-Gamonet V, Belin D, Piazza PV, (2004) Evidence for addiction-like behavior in the rat. Science 305: 1014-1017.
9. Kasanetz F, Deroche-Gamonet V, Berson N, Balado E, Lafourcade M, et al. (2010) Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science 328: 1709-1712.
10. Lopez-Quintero C, Perez de los Cobos J, Hasin DS, Okuda M, Wang S, et al. (2011) Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 115: 120-130.
11. Vink JM, Willemsen G, Boomsma DI, (2005) Heritability of smoking initiation and nicotine dependence. Behav Genet 35: 397-406.
12. Koob GF, (2008) Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking Behavior. Drug Discov Today Dis Models 5: 207-215.
13. Zhang D, Shao C, Shao M, Yan P, Wang Y, et al. (2007) Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry 61: 1244-1251.
14. Lett BT, (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98: 357-362.
15. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Minarro J, (2005) Sensitization to the rewarding effects of morphine depends on dopamine. Neuroreport 16: 201-205.
16. Koob GF, Le Moal M, (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129.
17. Wise RA, Rompre PP, (1989) Brain dopamine and reward. Annu Rev Psychol 40: 191-225.
18. Yacubian J, Buchel C, (2009) The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. Neuroscience 164: 55-71.
19. Jacobs MM, Okvist A, Horvath M, Keller E, Bannon MJ, et al. (2012) Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Mol Psychiatry.
20. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, et al. (2008) Significant association of DRD1 with nicotine dependence. Hum Genet 123: 133-140.
21. Kim DJ, Park BL, Yoon S, Lee HK, Joe KH, et al. (2007) 5′ UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism. Biochem Biophys Res Commun 357: 1135-1141.
22. da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, et al. (2007) Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud 23: 421-433.
23. Zhu F, Yan CX, Wang Q, Zhu YS, Zhao Y, et al. (2011) An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. Brain Res 1420: 106-113.
24. Hettinger JA, Liu X, Schwartz CE, Michaelis RC, Holden JJ, (2008) A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families. Am J Med Genet B Neuropsychiatr Genet 147B: 628-636.
25. Huang W, Li MD, (2009) Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry 65: 702-705.
26. Jurinke C, van den Boom D, Cantor CR, Koster H, (2002) Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187: 179-192.
27. Dupont WD, Plummer WD Jr, (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19: 589-601.
28. Barrett JC, (2009) Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009: pdb ip71.
29. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS, (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8: 1450-1457.
30. Depue RA, Collins PF, (1999) Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22: 491-517 discussion 518-469.
31. Wise RA, (2000) Addiction becomes a brain disease. Neuron 26: 27-33.
32. Piazza PV, Deroche-Gamonent V, Rouge-Pont F, Le Moal M, (2000) Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci 20: 4226-4232.
33. Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, et al. (2007) Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27: 13140-13150.
34. Gerrits MA, Ramsey NF, Wolterink G, van Ree JM, (1994) Lack of evidence for an involvement of nucleus accumbens dopamine D1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology (Berl) 114: 486-494.
35. Glick SD, Cox RD, (1975) Dopaminergic and cholinergic influences on morphine self-administration in rats. Res Commun Chem Pathol Pharmacol 12: 17-24.
36. Rowlett JK, Platt DM, Yao WD, Spealman RD, (2007) Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 321: 1135-1143.
37. Liu J, Nickolenko J, Sharp FR, (1994) Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 91: 8537-8541.
38. Muller DL, Unterwald EM, (2005) D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 314: 148-154.
39. Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, et al. (2006) An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci 9: 205-211.
40. Borgkvist A, Valjent E, Santini E, Herve D, Girault JA, et al. (2008) Delayed, context- and dopamine D1 receptor-dependent activation of ERK in morphine-sensitized mice. Neuropharmacology 55: 230-237.
41. Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, et al. (2003) Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 87: 922-934.
42. Nestler EJ, (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47 Suppl 1: 24-32.
43. Kauer JA, Malenka RC, (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8: 844-858.
44. Wise RA, Leone P, Rivest R, Leeb K, (1995) Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse 21: 140-148.
45. Hilario MR, Turner JR, Blendy JA, (2012) Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. Neuropsychopharmacology 37: 2661-2670.
46. Bie B, Wang Y, Cai YQ, Zhang Z, Hou YY, et al. (2012) Upregulation of Nerve Growth Factor in Central Amygdala Increases Sensitivity to Opioid Reward. Neuropsychopharmacology.
47. Kourrich S, Klug JR, Mayford M, Thomas MJ, (2012) AMPAR-independent effect of striatal alphaCaMKII promotes the sensitization of cocaine reward. J Neurosci 32: 6578-6586.
48. Lintas A, Chi N, Lauzon NM, Bishop SF, Gholizadeh S, et al. (2011) Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit. J Neurosci 31: 11172-11183.
49. Bahi A, Dreyer JL, (2012) Involvement of nucleus accumbens dopamine D1 receptors in ethanol drinking, ethanol-induced conditioned place preference, and ethanol-induced psychomotor sensitization in mice. Psychopharmacology (Berl) 222: 141-153.
50. Zhang J, Wang J, Wu Y, (2012) An improved approach for accurate and efficient calling of structural variations with low-coverage sequence data. BMC Bioinformatics 13 Suppl 6: S6.